Works matching IS 20367449 AND DT 2022 AND VI 14 AND IP 2


Results: 15
    1
    2

    Evaluating the Use of Dalbavancin for Off-Label Indications.

    Published in:
    Infectious Disease Reports, 2022, v. 14, n. 2, p. 266, doi. 10.3390/idr14020032
    By:
    • Taylor, Katherine;
    • Williamson, John;
    • Luther, Vera;
    • Stone, Tyler;
    • Johnson, James;
    • Gruss, Zachary;
    • Russ-Friedman, Courtney;
    • Ohl, Chris;
    • Beardsley, James
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Acute Stroke Care during COVID-19: National Data.

    Published in:
    Infectious Disease Reports, 2022, v. 14, n. 2, p. 198, doi. 10.3390/idr14020024
    By:
    • Miękisiak, Grzegorz;
    • Pettersson, Samuel D.;
    • Szarek, Dariusz;
    • Morasiewicz, Piotr;
    • Fercho, Justyna;
    • Adamski, Stanisław;
    • Kipiński, Lech;
    • Szmuda, Tomasz
    Publication type:
    Article
    11
    12
    13
    14

    Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial.

    Published in:
    Infectious Disease Reports, 2022, v. 14, n. 2, p. 160, doi. 10.3390/idr14020020
    By:
    • Beltran Gonzalez, Jose Lenin;
    • González Gámez, Mario;
    • Mendoza Enciso, Emanuel Antonio;
    • Esparza Maldonado, Ramiro Josue;
    • Hernández Palacios, Daniel;
    • Dueñas Campos, Samuel;
    • Robles, Itzel Ovalle;
    • Macías Guzmán, Mariana Jocelyn;
    • García Díaz, Andrea Lucia;
    • Gutiérrez Peña, César Mauricio;
    • Martinez Medina, Lucila;
    • Monroy Colin, Victor Antonio;
    • Arreola Guerra, Jose Manuel
    Publication type:
    Article